- Home
- EPSN vs LXRX Comparison
EPSN vs LXRX Comparison
Compare EPSN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSN
- LXRX
- Stock Information
- Founded
- EPSN 2005
- LXRX 1995
- Country
- EPSN Canada
- LXRX United States
- Employees
- EPSN N/A
- LXRX N/A
- Industry
- EPSN Oil & Gas Production
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EPSN Energy
- LXRX Health Care
- Exchange
- EPSN Nasdaq
- LXRX Nasdaq
- Market Cap
- EPSN 153.4M
- LXRX 124.4M
- IPO Year
- EPSN N/A
- LXRX 2000
- Fundamental
- Price
- EPSN $6.48
- LXRX $0.58
- Analyst Decision
- EPSN Strong Buy
- LXRX Buy
- Analyst Count
- EPSN 1
- LXRX 4
- Target Price
- EPSN $7.00
- LXRX $3.67
- AVG Volume (30 Days)
- EPSN 52.0K
- LXRX 32.4M
- Earning Date
- EPSN 05-07-2025
- LXRX 05-01-2025
- Dividend Yield
- EPSN 3.81%
- LXRX N/A
- EPS Growth
- EPSN N/A
- LXRX N/A
- EPS
- EPSN 0.09
- LXRX N/A
- Revenue
- EPSN $31,522,775.00
- LXRX $31,081,000.00
- Revenue This Year
- EPSN $41.35
- LXRX N/A
- Revenue Next Year
- EPSN N/A
- LXRX $63.36
- P/E Ratio
- EPSN $74.63
- LXRX N/A
- Revenue Growth
- EPSN 2.58
- LXRX 2481.48
- 52 Week Low
- EPSN $4.95
- LXRX $0.28
- 52 Week High
- EPSN $7.32
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- EPSN 47.11
- LXRX 59.57
- Support Level
- EPSN $6.06
- LXRX $0.48
- Resistance Level
- EPSN $6.81
- LXRX $0.60
- Average True Range (ATR)
- EPSN 0.37
- LXRX 0.08
- MACD
- EPSN -0.03
- LXRX 0.01
- Stochastic Oscillator
- EPSN 36.36
- LXRX 89.58
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.